Anesthesia Recommendations for a 55-Year-Old Male with CAD and Stents Undergoing Cystoscopy for Hydronephrosis
For this patient with coronary artery disease and stents undergoing cystoscopy for hydronephrosis, monitored anesthesia care with careful hemodynamic monitoring is strongly recommended to minimize cardiovascular risk.
Preoperative Assessment
Cardiac Status Evaluation:
- Assess current stent status (type and time since placement)
- Determine if patient is on dual antiplatelet therapy
- Review most recent cardiac function tests (ECG, echocardiogram)
- Evaluate for symptoms of angina or heart failure
Renal Function Assessment:
- Check baseline creatinine and eGFR
- Assess hydration status
- Review electrolytes, especially potassium
Anesthetic Approach
Recommended Technique
- Monitored Anesthesia Care (MAC) with local anesthesia is preferred for this low-risk procedure 1
- If general anesthesia is required, use a balanced technique with careful titration of agents
Hemodynamic Goals
- Maintain hemodynamic stability with particular attention to:
- Avoid tachycardia (maintain heart rate <80 bpm)
- Maintain systolic blood pressure within 20% of baseline
- Avoid hypotension which may decrease coronary perfusion pressure 1
Medication Considerations
Anesthetic Agents:
- Use lidocaine or mepivacaine for local anesthesia
- If sedation needed: titrated midazolam and fentanyl
- If general anesthesia required: etomidate or reduced-dose propofol for induction
Antiplatelet Management:
- Continue aspirin perioperatively
- Consult with cardiologist regarding management of P2Y12 inhibitors (clopidogrel, ticagrelor)
- If stent placement was recent (<6 months for DES, <1 month for BMS), consider postponing elective procedure
Intraoperative Management
Monitoring:
- Standard ASA monitors plus:
- Continuous arterial blood pressure monitoring if patient has unstable CAD
- Consider intraoperative TEE if patient has significant cardiac dysfunction 1
Fluid Management:
- Use isotonic crystalloids (normal saline or lactated Ringer's)
- Avoid fluid overload that could exacerbate hydronephrosis
- Target euvolemia with careful titration
Contrast Media Considerations:
Postoperative Care
Monitoring Period:
- Continue hemodynamic monitoring for 1-2 hours post-procedure
- Monitor for cardiac symptoms (chest pain, dyspnea, arrhythmias)
- Check ECG if any concerning symptoms develop
Pain Management:
- Use multimodal analgesia with acetaminophen and low-dose opioids as needed
- Avoid NSAIDs due to potential renal effects in a patient with hydronephrosis
Fluid Management:
- Continue IV fluids until adequate oral intake is established
- Monitor urine output to ensure resolution of obstruction
- Check post-procedure creatinine if contrast was used
Potential Complications and Management
Cardiac Events:
Urologic Complications:
- Monitor for signs of urinary tract infection post-procedure
- Ensure adequate drainage of hydronephrosis was achieved
Key Pitfalls to Avoid
- Neglecting antiplatelet management - Inappropriate discontinuation of antiplatelet therapy can lead to stent thrombosis
- Inadequate hemodynamic monitoring - Failure to detect and promptly treat hemodynamic instability
- Overlooking renal function - Not accounting for potential worsening of renal function with contrast use
- Fluid mismanagement - Either excessive or insufficient fluid administration can worsen cardiac and renal outcomes
By following these recommendations, the anesthesiologist can minimize cardiovascular risk while providing appropriate anesthesia care for this patient's cystoscopy procedure.